Join the club for FREE to access the whole archive and other member benefits.

Ashley Zehnder

Co-founder and CEO at Fauna Bio

Veterinarian-scientist, Co-founder and CEO at Fauna Bio.

Ashley’s research focused on translational science and veterinary informatics at Stanford, earning a PhD in Cancer Biology and her work spans >20 peer-reviewed publications, including Cell, Nature and Nature Medicine and several book chapters. She is a boarded avian veterinarian with specialty training in exotic/non-traditional species. She is a co-founder of the Exotic Species Cancer Research Alliance and incoming president of the Association of Avian Veterinarians.


Visit website: https://www.faunabio.com/blog/founder-story-ashley-zehnder

 ashley-zehnder-31950827

See also: Company Fauna Bio - Developing human therapeutics from animal genomics

Details last updated 06-Sep-2021

Ashley Zehnder News

Fauna Bio hunts for novel obesity drugs in $494m Lilly partnership

Fauna Bio hunts for novel obesity drugs in $494m Lilly partnership

Longevity Technology - 21-Dec-2023

Fauna's AI platform explores animal data to unlock breakthroughs in weight management

Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit

Lifespan.io summarises the proceedings of the Buck Institute's Longevity Summit

Lifespan.io (LEAF) - 20-Jan-2023

Another reminder of the amount of research, with multiple approaches, about to go into clinical trials

Fauna Bio finds new avenues for drug discovery through animal genomics

Fauna Bio finds new avenues for drug discovery through animal genomics

Longevity Technology - 27-Aug-2021

By investigating self-healing mechanisms in animals, Fauna bio aims to cure human diseases.